Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Qiaojing Capital is an investment firm that invests in the medical, consumer &a; supply chain financial management industries. Qiao Jing Capital&s;s core operation team has experience in senior management positions in well-known asset management companies at home and abroad. The company&s;s operations fully follow the leading models at home and abroad, and pursue strict risk management and efficient incentive mechanisms.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
10/2020 | Leto Laboratories | Series B | 14.9M |
1/2018 | Innostic | Series A | 39.5M |
12/2016 | Wanshang Yizhan | Series A | 2.9M |
9/2017 | ZHENG HENG | Post-IPO Equity | 30.6M |
1/2017 | Replays | Series A | 1.5M |
3/2016 | EO Company | Series A | - |
3/2017 | Hongjitang | Post-IPO Equity | 37.8M |
7/2015 | Hongjitang | Venture Round | 8.1M |
7/2016 | POINT | Post-IPO Equity | 1.5M |
8/2018 | Wanxu Software | Series A | 2.9M |
7/2015 | guojing.net | Angel Round | 485.1k |
6/2015 | EO Company | Series A | 1.6M |
2/2017 | Oranger | Series B | 10.2M |
4/2015 | Lungcare | Series A | 1.6M |
11/2016 | Qianxing Group | Series A | 1.4M |
8/2016 | Entmagine | Angel Round | 452.4k |
11/2016 | 99 Interaction Entertainment | Post-IPO Equity | 1.5M |
9/2016 | Lungcare | Series B | 3M |
7/2014 | Dianwoda | Series B | 10M |
10/2020 | Leto Laboratories | Series B | 0 |
8/2018 | Wanxu Software | Series A | 0 |
1/2018 | Innostic | Series A | 0 |
9/2017 | ZHENG HENG | Post-IPO Equity | 0 |
3/2017 | Hongjitang | Post-IPO Equity | 0 |
2/2017 | Oranger | Series B | 0 |
1/2017 | Replays | Series A | 0 |
12/2016 | Wanshang Yizhan | Series A | 0 |
11/2016 | Qianxing Group | Series A | 0 |
11/2016 | 99 Interaction Entertainment | Post-IPO Equity | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|